The efficacy of technical pyriproxyfen and diflubenzuron was evaluated at the laboratory level against Aedes aegypti, where we achieved adult emergence inhibition (EI50) values of 0.048 and 1.59 ppb (µg/liter), respectively. We compared these data with values obtained for temephos. We prepared emulsifiable concentrate formulations of pyriproxyfen and diflubenzuron in the laboratory and obtained EI50 values of 0.01 and 0.02 ppb, respectively. We also obtained 100% adult emergence inhibition with 0.1% slow-release sand formulations of pyriproxyfen and diflubenzuron. In a simulated field study, the granular sand formulations of pyriproxyfen, diflubenzuron, and temephos remained active for over 4 mo. In a field study, a 0.2% granular formulation of diflubenzuron and 1% temephos showed a similar performance.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 24 • No. 3